Isolated limb perfusion in the sarcoma-bearing rat

A novel preclinical gene delivery system

Kresimira Milas, Barry Feig, Dihua Yu, Noboru Oriuchi, Douglas Cromeens, Tong Ge, Franklin C. Wong, E. Edmund Kim, Raphael Pollock

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Reliable site-specific delivery of genetic constructs remains a challenging component of gene-based therapy of solid tumors. Isolated limb perfusion (ILP) continues to be evaluated for treatment of locally advanced soft tissue sarcomas because this approach uniquely directs therapeutic agents into the tumor-bearing extremity without significant systemic leak. In light of these considerations, we tested the hypothesis that ILP could be used to deliver genes carried in viral vectors to the sarcoma-bearing rat extremity, resulting in demonstrable gene transfer into the tumor. ILP was performed in rats by cannulating the femoral artery and vein, isolating the hind limb from systemic circulation by tourniquet, and cycling perfusate for 15 min at a rate of 2.4 ml/min. Leakage into the systemic circulation was 7.5% of the total perfusate concentrated in the isolated limb, as determined by perfusion with technetium 99m-tagged RBCs. We used the ILP technique to perfuse rat hind limbs bearing syngeneic fibrosarcoma tumor nodules with the replication-defective adenovirus Ad5LacZ, which expresses the bacterial β- galactosidase. 5-Bromo-4-chloro-3-indolyl-β-D-galactoside staining of the perfused limb tissues confirmed gene transfer to the tumor and peritumoral tissue, demonstrating that the tumor was part of the perfusion circuit and that gene therapy delivered via this method was feasible. These results suggest that adaptation of this preclinical gene delivery model to administer genetic constructs aimed at controlling tumor growth may prove beneficial to patients with extremity sarcomas.

Original languageEnglish (US)
Pages (from-to)2197-2203
Number of pages7
JournalClinical Cancer Research
Volume3
Issue number12 I
StatePublished - Dec 1997
Externally publishedYes

Fingerprint

Gene Transfer Techniques
Sarcoma
Extremities
Perfusion
Neoplasms
Genetic Therapy
Genes
Galactosidases
Galactosides
Tourniquets
Femoral Vein
Fibrosarcoma
Technetium
Femoral Artery
Adenoviridae

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Milas, K., Feig, B., Yu, D., Oriuchi, N., Cromeens, D., Ge, T., ... Pollock, R. (1997). Isolated limb perfusion in the sarcoma-bearing rat: A novel preclinical gene delivery system. Clinical Cancer Research, 3(12 I), 2197-2203.

Isolated limb perfusion in the sarcoma-bearing rat : A novel preclinical gene delivery system. / Milas, Kresimira; Feig, Barry; Yu, Dihua; Oriuchi, Noboru; Cromeens, Douglas; Ge, Tong; Wong, Franklin C.; Kim, E. Edmund; Pollock, Raphael.

In: Clinical Cancer Research, Vol. 3, No. 12 I, 12.1997, p. 2197-2203.

Research output: Contribution to journalArticle

Milas, K, Feig, B, Yu, D, Oriuchi, N, Cromeens, D, Ge, T, Wong, FC, Kim, EE & Pollock, R 1997, 'Isolated limb perfusion in the sarcoma-bearing rat: A novel preclinical gene delivery system', Clinical Cancer Research, vol. 3, no. 12 I, pp. 2197-2203.
Milas K, Feig B, Yu D, Oriuchi N, Cromeens D, Ge T et al. Isolated limb perfusion in the sarcoma-bearing rat: A novel preclinical gene delivery system. Clinical Cancer Research. 1997 Dec;3(12 I):2197-2203.
Milas, Kresimira ; Feig, Barry ; Yu, Dihua ; Oriuchi, Noboru ; Cromeens, Douglas ; Ge, Tong ; Wong, Franklin C. ; Kim, E. Edmund ; Pollock, Raphael. / Isolated limb perfusion in the sarcoma-bearing rat : A novel preclinical gene delivery system. In: Clinical Cancer Research. 1997 ; Vol. 3, No. 12 I. pp. 2197-2203.
@article{c13a175495ab4fc3b6510cef97472558,
title = "Isolated limb perfusion in the sarcoma-bearing rat: A novel preclinical gene delivery system",
abstract = "Reliable site-specific delivery of genetic constructs remains a challenging component of gene-based therapy of solid tumors. Isolated limb perfusion (ILP) continues to be evaluated for treatment of locally advanced soft tissue sarcomas because this approach uniquely directs therapeutic agents into the tumor-bearing extremity without significant systemic leak. In light of these considerations, we tested the hypothesis that ILP could be used to deliver genes carried in viral vectors to the sarcoma-bearing rat extremity, resulting in demonstrable gene transfer into the tumor. ILP was performed in rats by cannulating the femoral artery and vein, isolating the hind limb from systemic circulation by tourniquet, and cycling perfusate for 15 min at a rate of 2.4 ml/min. Leakage into the systemic circulation was 7.5{\%} of the total perfusate concentrated in the isolated limb, as determined by perfusion with technetium 99m-tagged RBCs. We used the ILP technique to perfuse rat hind limbs bearing syngeneic fibrosarcoma tumor nodules with the replication-defective adenovirus Ad5LacZ, which expresses the bacterial β- galactosidase. 5-Bromo-4-chloro-3-indolyl-β-D-galactoside staining of the perfused limb tissues confirmed gene transfer to the tumor and peritumoral tissue, demonstrating that the tumor was part of the perfusion circuit and that gene therapy delivered via this method was feasible. These results suggest that adaptation of this preclinical gene delivery model to administer genetic constructs aimed at controlling tumor growth may prove beneficial to patients with extremity sarcomas.",
author = "Kresimira Milas and Barry Feig and Dihua Yu and Noboru Oriuchi and Douglas Cromeens and Tong Ge and Wong, {Franklin C.} and Kim, {E. Edmund} and Raphael Pollock",
year = "1997",
month = "12",
language = "English (US)",
volume = "3",
pages = "2197--2203",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "12 I",

}

TY - JOUR

T1 - Isolated limb perfusion in the sarcoma-bearing rat

T2 - A novel preclinical gene delivery system

AU - Milas, Kresimira

AU - Feig, Barry

AU - Yu, Dihua

AU - Oriuchi, Noboru

AU - Cromeens, Douglas

AU - Ge, Tong

AU - Wong, Franklin C.

AU - Kim, E. Edmund

AU - Pollock, Raphael

PY - 1997/12

Y1 - 1997/12

N2 - Reliable site-specific delivery of genetic constructs remains a challenging component of gene-based therapy of solid tumors. Isolated limb perfusion (ILP) continues to be evaluated for treatment of locally advanced soft tissue sarcomas because this approach uniquely directs therapeutic agents into the tumor-bearing extremity without significant systemic leak. In light of these considerations, we tested the hypothesis that ILP could be used to deliver genes carried in viral vectors to the sarcoma-bearing rat extremity, resulting in demonstrable gene transfer into the tumor. ILP was performed in rats by cannulating the femoral artery and vein, isolating the hind limb from systemic circulation by tourniquet, and cycling perfusate for 15 min at a rate of 2.4 ml/min. Leakage into the systemic circulation was 7.5% of the total perfusate concentrated in the isolated limb, as determined by perfusion with technetium 99m-tagged RBCs. We used the ILP technique to perfuse rat hind limbs bearing syngeneic fibrosarcoma tumor nodules with the replication-defective adenovirus Ad5LacZ, which expresses the bacterial β- galactosidase. 5-Bromo-4-chloro-3-indolyl-β-D-galactoside staining of the perfused limb tissues confirmed gene transfer to the tumor and peritumoral tissue, demonstrating that the tumor was part of the perfusion circuit and that gene therapy delivered via this method was feasible. These results suggest that adaptation of this preclinical gene delivery model to administer genetic constructs aimed at controlling tumor growth may prove beneficial to patients with extremity sarcomas.

AB - Reliable site-specific delivery of genetic constructs remains a challenging component of gene-based therapy of solid tumors. Isolated limb perfusion (ILP) continues to be evaluated for treatment of locally advanced soft tissue sarcomas because this approach uniquely directs therapeutic agents into the tumor-bearing extremity without significant systemic leak. In light of these considerations, we tested the hypothesis that ILP could be used to deliver genes carried in viral vectors to the sarcoma-bearing rat extremity, resulting in demonstrable gene transfer into the tumor. ILP was performed in rats by cannulating the femoral artery and vein, isolating the hind limb from systemic circulation by tourniquet, and cycling perfusate for 15 min at a rate of 2.4 ml/min. Leakage into the systemic circulation was 7.5% of the total perfusate concentrated in the isolated limb, as determined by perfusion with technetium 99m-tagged RBCs. We used the ILP technique to perfuse rat hind limbs bearing syngeneic fibrosarcoma tumor nodules with the replication-defective adenovirus Ad5LacZ, which expresses the bacterial β- galactosidase. 5-Bromo-4-chloro-3-indolyl-β-D-galactoside staining of the perfused limb tissues confirmed gene transfer to the tumor and peritumoral tissue, demonstrating that the tumor was part of the perfusion circuit and that gene therapy delivered via this method was feasible. These results suggest that adaptation of this preclinical gene delivery model to administer genetic constructs aimed at controlling tumor growth may prove beneficial to patients with extremity sarcomas.

UR - http://www.scopus.com/inward/record.url?scp=0031427397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031427397&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 2197

EP - 2203

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 12 I

ER -